SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
August 3, 2001
Date of report (Date of earliest event reported)
GalaGen Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
| 0-27976 |
| 41-1719104 |
(State of Incorporation) |
| (Commission File Number) |
| (I.R.S. Employer Identification No.) |
301 Carlson Parkway , Suite 301 |
|
|
(Address of Principal Executive Offices) |
| (Zip Code) |
Telephone Number: (952) 258-5500
(Registrant’s Telephone Number, Including Area Code)
This amendment to Current Report on Form 8-K of GalaGen Inc. is filed for the purpose of filing the pro forma financial information required by Item 7(b).
Item 7. Financial Statements and Exhibits.
(b) Pro Forma Financial Information
The following unaudited pro forma financial statements are attached hereto as Exhibit 99:
Pro Forma Balance Sheet as of June 30, 2001
Pro Forma Statement of Operations for the year ended December 31, 2000 and for the six months ended June 30, 2001
Notes to Pro Forma Financial Statements
(c) Exhibits
2 Asset Purchase Agreement by and between Hormel HealthLabs, Inc. and GalaGen Inc., dated as of August 2, 2001.
99 Pro Forma Financial Information
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 15, 2001
|
|
|
| GALAGEN INC. | |
|
|
|
| (Registrant) | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| By | /s/ Henry J. Cardello |
|
|
|
|
| Henry J. Cardello |
|
|
|
|
| President and Chief Executive Officer |
INDEX TO EXHIBITS
Exhibit No. |
|
|
|
|
|
2 |
| Asset Purchase Agreement by and between Hormel HealthLabs, Inc. and GalaGen Inc., dated as of August 2, 2001. (Previously filed.) |
|
|
|
99 |
| Pro Forma Financial Information |
